Codivir
Peptideexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 29, 2021 (NCT04930861)
Timeline
Indications
Mechanism of action
- SARS-CoV-2INHIBITOR
inhibitor - SARS-CoV-2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06676410 | Phase 2 | Jul 20, 2023 | Code Pharma, Galilee CBR |
| NCT05218356 | Phase 2 | Jan 20, 2022 | Code Pharma |
| NCT04930861 | Phase 1 | Mar 29, 2021 | Code Pharma |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Code Pharma | For profit | 3 | 3 | 2 | 2021 |
| Galilee CBR | Academic/Hospital | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1